Insider · CIK 0002027261

Garfield Alastair

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0002027261

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-13	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−2,007 sh	$116.11	−$233K	8,051
2026-08-13	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−1,556 sh	$117.08	−$182K	6,495
2026-08-13	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−3,400 sh	$118.28	−$402K	3,095
2026-08-13	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−800 sh	$119.17	−$95.3K	2,295
2026-07-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,445 sh	—	—	12,208
2026-07-01	RYTMRHYTHM PHARMACEUTICALS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−2,150 sh	$110.41	−$237K	10,058
2026-07-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,445 sh	—	—	8,888
2026-02-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+16.7K sh	—	—	16,650
2026-02-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)A Award	Chief Scientific Officer	AAward	+25K sh	—	—	25,000
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,663 sh	—	—	9,789
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−2,026 sh	$108.99	−$221K	7,763
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,663 sh	—	—	19,987
2025-07-02	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−1,313 sh	$64.81	−$85.1K	3,132
2025-07-02	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−6 sh	$64.60	−$387.6	3,126
2025-07-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,445 sh	—	—	4,445
2025-07-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,445 sh	—	—	13,333
2025-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+26.7K sh	—	—	26,650
2025-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)A Award	Chief Scientific Officer	AAward	+40K sh	—	—	40,000
2024-07-08	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+53.3K sh	—	—	53,333
2024-07-08	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+17.8K sh	—	—	17,778

Recent filings

Accepted (ET)
Aug 174
Garfield Alastair0001649904-26-000013
SEC(opens sec.gov)
Jul 24
Garfield Alastair0001104659-26-080397
SEC(opens sec.gov)
Feb 134
Garfield Alastair0001104659-26-015397
SEC(opens sec.gov)
Feb 34
Garfield Alastair0001104659-26-009764
SEC(opens sec.gov)
Jul 34
Garfield Alastair0001104659-25-065844
SEC(opens sec.gov)
Feb 194
Garfield Alastair0001104659-25-015318
SEC(opens sec.gov)
Jul 104
Garfield Alastair0001104659-24-078983
SEC(opens sec.gov)

Companies

RHYTHM PHARMACEUTICALS, INC.Chief Scientific OfficerRYTM

Address

C/O RHYTHM PHARMACEUTICALS, INC. 222 BERKELEY STREET, 12TH FLOOR

BOSTON, MA, 02116